Free Trial

Fresenius Medical Care (ETR:FME) Stock Price Passes Above Two Hundred Day Moving Average - What's Next?

Fresenius Medical Care logo with Medical background

Fresenius Medical Care AG (ETR:FME - Get Free Report)'s share price passed above its 200-day moving average during trading on Friday . The stock has a 200-day moving average of €37.11 ($40.78) and traded as high as €39.52 ($43.43). Fresenius Medical Care shares last traded at €39.18 ($43.05), with a volume of 356,730 shares traded.

Fresenius Medical Care Stock Performance

The company has a debt-to-equity ratio of 77.56, a quick ratio of 0.80 and a current ratio of 1.46. The company has a market capitalization of $11.65 billion, a price-to-earnings ratio of 21.93, a P/E/G ratio of 0.42 and a beta of 0.86. The firm's 50 day simple moving average is €37.18 and its 200-day simple moving average is €37.11.

About Fresenius Medical Care

(Get Free Report)

Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.

See Also

Should you invest $1,000 in Fresenius Medical Care right now?

Before you consider Fresenius Medical Care, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.

While Fresenius Medical Care currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Beginners Guide To Retirement Stocks Cover

Click the link below and we'll send you MarketBeat's list of seven best retirement stocks and why they should be in your portfolio.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

Massive Market Moves Following Trump Win: Tesla, JP Morgan, & Bitcoin Soar

MarketBeat analyst Thomas Hughes breaks down the biggest winners of the day, including Tesla, JP Morgan, and the Russell 2000, and why they’re surging.

Related Videos

Tesla Stock Rockets 15% Post-Earnings
Tesla Stock: Profits vs. Price—Is It Time to Sell?
Top Stocks to Buy, Sell, and Hold Right Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines